Clinical Trial Update: Phase I/II Open Label Study of Belumosudil Mesylate Alone, and in Combination With Dexamethasone, in Patients With Relapsed/Refractory Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/2 open-label study of belumosudil mesylate, alone and in combination with dexamethasone, in patients with relapse…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Belumosudil Mesylate (belumosudil)
• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: RECRUITING